These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Phytotherapeuthics Affecting the IL-1/IL-17/G-CSF Axis: A Complementary Treatment Option for Hidradenitis Suppurativa? Witte K; Sabat R; Witte-Händel E; Ghoreschi K; Wolk K Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012322 [TBL] [Abstract][Full Text] [Related]
4. High inflammation in hidradenitis suppurativa extends to perilesional skin and can be subdivided by lipocalin-2 expression. Navrazhina K; Garcet S; Zheng X; Hur HB; Frew JW; Krueger JG J Allergy Clin Immunol; 2022 Jan; 149(1):135-144.e12. PubMed ID: 34081946 [TBL] [Abstract][Full Text] [Related]
5. B-cell maturation antigen (BCMA) activation exerts specific proinflammatory effects in normal human keratinocytes and is preferentially expressed in inflammatory skin pathologies. Alexaki VI; Pelekanou V; Notas G; Venihaki M; Kampa M; Dessirier V; Sabour-Alaoui S; Stathopoulos EN; Tsapis A; Castanas E Endocrinology; 2012 Feb; 153(2):739-49. PubMed ID: 22166983 [TBL] [Abstract][Full Text] [Related]
6. CSL324, a granulocyte colony-stimulating factor receptor antagonist, blocks neutrophil migration markers that are upregulated in hidradenitis suppurativa. Gamell C; Bankovacki A; Scalzo-Inguanti K; Sedgmen B; Alhamdoosh M; Gail E; Turkovic L; Millar C; Johnson L; Wahlsten M; Richter J; Schuster J; Dyson A; Nicolopoulos J; Varigos G; Ng M; Wilson N; Field J; Kern JS; Lindqvist LM Br J Dermatol; 2023 Apr; 188(5):636-648. PubMed ID: 36691791 [TBL] [Abstract][Full Text] [Related]
7. Lipocalin-2 is expressed by activated granulocytes and keratinocytes in affected skin and reflects disease activity in acne inversa/hidradenitis suppurativa. Wolk K; Wenzel J; Tsaousi A; Witte-Händel E; Babel N; Zelenak C; Volk HD; Sterry W; Schneider-Burrus S; Sabat R Br J Dermatol; 2017 Nov; 177(5):1385-1393. PubMed ID: 28256718 [TBL] [Abstract][Full Text] [Related]
8. Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar. Lovrić I; Brkić J; Ćorluka M; Čović M; Pejić J; Zeljko Penavić J Acta Dermatovenerol Croat; 2021 Jul; 29(2):108-110. PubMed ID: 34477078 [TBL] [Abstract][Full Text] [Related]
9. Tertiary lymphoid structures sustain cutaneous B cell activity in hidradenitis suppurativa. Lowe MM; Cohen JN; Moss MI; Clancy S; Adler JP; Yates AE; Naik HB; Yadav R; Pauli M; Taylor I; McKay A; Harris H; Kim E; Hansen SL; Rosenblum MD; Moreau JM JCI Insight; 2024 Feb; 9(3):. PubMed ID: 38113104 [TBL] [Abstract][Full Text] [Related]
11. Inflammation induced changes in the expression levels of components of the microRNA maturation machinery Drosha, Dicer, Drosha co-factor DGRC8 and Exportin-5 in inflammatory lesions of hidradenitis suppurativa patients. Hessam S; Sand M; Skrygan M; Gambichler T; Bechara FG J Dermatol Sci; 2016 Jun; 82(3):166-74. PubMed ID: 26917346 [TBL] [Abstract][Full Text] [Related]
12. The P2X7 Receptor Is Overexpressed in the Lesional Skin of Subjects Affected by Hidradenitis Suppurativa: A Preliminary Study. Manfredini M; Giuliani AL; Ruina G; Gafà R; Bosi C; Zoppas E; Di Virgilio F; Bettoli V Dermatology; 2021; 237(1):111-118. PubMed ID: 31454821 [TBL] [Abstract][Full Text] [Related]
14. The IL-1 Pathway Is Hyperactive in Hidradenitis Suppurativa and Contributes to Skin Infiltration and Destruction. Witte-Händel E; Wolk K; Tsaousi A; Irmer ML; Mößner R; Shomroni O; Lingner T; Witte K; Kunkel D; Salinas G; Jodl S; Schmidt N; Sterry W; Volk HD; Giamarellos-Bourboulis EJ; Pokrywka A; Döcke WD; Schneider-Burrus S; Sabat R J Invest Dermatol; 2019 Jun; 139(6):1294-1305. PubMed ID: 30528824 [TBL] [Abstract][Full Text] [Related]
15. Eosinophils in hidradenitis suppurativa patients exhibit pro-inflammatory traits, implicating a potential pathogenic role in the disease. Renert-Yuval Y; Gonzalez J; Garcet S; Williams SC; Moreno A; Krueger JG Exp Dermatol; 2024 Jul; 33(7):e15129. PubMed ID: 38984465 [TBL] [Abstract][Full Text] [Related]
16. Alterations in leucocyte subsets and histomorphology in normal-appearing perilesional skin and early and chronic hidradenitis suppurativa lesions. van der Zee HH; de Ruiter L; Boer J; van den Broecke DG; den Hollander JC; Laman JD; Prens EP Br J Dermatol; 2012 Jan; 166(1):98-106. PubMed ID: 21929531 [TBL] [Abstract][Full Text] [Related]
17. MMP8 Is Increased in Lesions and Blood of Acne Inversa Patients: A Potential Link to Skin Destruction and Metabolic Alterations. Tsaousi A; Witte E; Witte K; Röwert-Huber HJ; Volk HD; Sterry W; Wolk K; Schneider-Burrus S; Sabat R Mediators Inflamm; 2016; 2016():4097574. PubMed ID: 27843200 [TBL] [Abstract][Full Text] [Related]
18. Identifying key components and therapeutic targets of the immune system in hidradenitis suppurativa with an emphasis on neutrophils. Narla S; Azzam M; Townsend S; Vellaichamy G; Marzano AV; Alavi A; Lowes MA; Hamzavi IH Br J Dermatol; 2021 Jun; 184(6):1004-1013. PubMed ID: 32893875 [TBL] [Abstract][Full Text] [Related]
19. The microRNA effector RNA-induced silencing complex in hidradenitis suppurativa: a significant dysregulation within active inflammatory lesions. Hessam S; Sand M; Skrygan M; Bechara FG Arch Dermatol Res; 2017 Sep; 309(7):557-565. PubMed ID: 28634830 [TBL] [Abstract][Full Text] [Related]
20. Epithelialized tunnels are a source of inflammation in hidradenitis suppurativa. Navrazhina K; Frew JW; Gilleaudeau P; Sullivan-Whalen M; Garcet S; Krueger JG J Allergy Clin Immunol; 2021 Jun; 147(6):2213-2224. PubMed ID: 33548397 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]